Leuprolide inj, camcevi, 1mg
Products billed under this code include Camcevi.
Payment limit per 1 mg, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Camcevi.
Payment limit per 1 mg, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Camcevi | Accord BioPharma, Inc | 69448-0014-63 | 42 | $1,527.666 |
| Camcevi | Accord BioPharma, Inc | 69448-0023-63 | 42 | $1,527.666 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $36.373 | −$5.686 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted September 17, 2026 |
| 3Q26 | $42.059 | +$2.112 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted September 15, 2026 |
| 2Q26 | $39.947 | −$17.087 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted September 15, 2026 |
| 1Q26 | $57.034 | −$21.882 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted September 15, 2026 |
| 4Q25 | $78.916 | +$27.511 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted September 8, 2026 |
| 3Q25 | $51.405 | −$0.973 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted March 10, 2026 |
| 2Q25 | $52.378 | −$3.527 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted March 10, 2026 |
| 1Q25 | $55.905 | +$0.906 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted December 19, 2025 |
| 4Q24 | $54.999 | −$0.638 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted June 11, 2025 |
| 3Q24 | $55.637 | −$5.117 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted June 11, 2025 |
| 2Q24 | $60.754 | +$0.954 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted March 11, 2025 |
| 1Q24 | $59.80 | −$14.549 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted December 19, 2024 |
| 4Q23 | $74.349 | −$3.959 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted October 10, 2024 |
| 3Q23 | $78.308 | −$20.121 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted June 5, 2024 |
| 2Q23 | $98.429 | +$9.678 | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted February 23, 2024 |
| 1Q23 | $88.751 | – | 1 mg | Leuprolide inj, camcevi, 1mg | v1, posted December 6, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.